Householder Group Estate & Retirement Specialist’s Anika Therapeutics ANIK Stock Holding History

Householder Group Estate & Retirement Specialist’s Portfolio ANIK Stock Details ANIK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$2K	Buy	+60	New	+$1.79K	﹤0.01%	1064

Other funds holding ANIK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $418M AUM 3.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.29% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Householder Group Estate & Retirement Specialist's ANIK Position: Q1 2023 in Review

Householder Group Estate & Retirement Specialist opened a new position in Anika Therapeutics (ANIK) in Q1 2023: 60 shares worth $2K. The stake represents ﹤0.01% of the portfolio and ranks #1064 among its holdings.

120 funds tracked by Wall St. Rank hold ANIK as of Q1 2023.

Householder Group Estate & Retirement Specialist held 60 shares of Anika Therapeutics worth $2K as of Q1 2023.
Anika Therapeutics was a new Householder Group Estate & Retirement Specialist position in Q1 2023.
Anika Therapeutics made up ﹤0.01% of Householder Group Estate & Retirement Specialist's portfolio in Q1 2023, its #1064 holding.
120 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2023.

Based on Householder Group Estate & Retirement Specialist's 13F filing for Q1 2023, filed 13 Apr 2023.